Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Dec 31, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $52.48B | $397.25 | -0.39% | $151.92M | 1,281.45x | 19.74 | United States | 45 |
| ONC | BEONE MEDICINES LTD | NASDAQ | Biotechnology | A | $33.75B | $304.72 | -1.80% | $318.03M | 6,094.40x | 0.85 | Cayman Islands | 53 |
| FIX | COMFORT SYSTEMS USA INC | NYSE | Engineering & Construction | A | $33.40B | $946.93 | -0.39% | $1.21B | 40.01x | 1.59 | United States | 61 |
| NVT | NVENT ELECTRIC PLC | NYSE | Electrical Equipment & Parts | A | $16.62B | $103.01 | -0.24% | $1.08B | 28.07x | 0.86 | United Kingdom | 42 |
| NBIX | NEUROCRINE BIOSCIENCES INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $14.05B | $140.95 | -1.87% | $679.20M | 32.70x | 0.42 | United States | 55 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.38B | $170.82 | 0.19% | $182.64M | -28.52x | 1.87 | Ireland | 16 |
| GTES | GATES INDUSTRIAL CORP PLC | NYSE | Specialty Industrial Machinery | A | $5.64B | $21.82 | -0.05% | $672.10M | 23.72x | 1.02 | United States | 37 |
| MIRM | MIRUM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $4.05B | $78.85 | -1.70% | -$592.00k | -92.76x | 1.69 | United States | 26 |
| CALX | CALIX INC | NYSE | Software - Application | A | $3.51B | $52.99 | -0.82% | $10.21M | -529.90x | 0.19 | United States | 28 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $2.86B | $49.89 | -2.65% | $64.66M | -151.18x | 0.35 | United States | 28 |
| SPNT | SIRIUSPOINT LTD | NYSE | Insurance - Reinsurance | A | $2.58B | $22.06 | -0.59% | $339.10M | 13.29x | 4.64 | Bermuda | 30 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.48B | $191.53 | -0.67% | $301.16M | 11.10x | 1.82 | United States | 52 |
| EXTR | EXTREME NETWORKS INC | NASDAQ | Communication Equipment | A | $2.26B | $16.89 | -0.18% | $65.83M | 241.29x | 15.82 | United States | 34 |
| ANIP | ANI PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $1.78B | $79.42 | -2.41% | $165.21M | 46.44x | 1.78 | United States | 50 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $1.61B | $7.66 | -0.65% | $83.87M | -153.20x | -2.15 | United States | 17 |
| BLBD | BLUE BIRD CORP | NASDAQ | Auto Manufacturers | A | $1.48B | $46.59 | -6.99% | $194.43M | 11.62x | 1.45 | United States | 52 |
| DNOW | DNOW INC | NYSE | Oil & Gas Equipment & Services | A | $1.41B | $13.45 | -0.88% | $165.00M | 15.11x | 0.40 | United States | 42 |
| ANAB | ANAPTYSBIO INC | NASDAQ | Biotechnology | A | $1.34B | $48.23 | -5.26% | -$82.14M | -17.60x | -13.00 | United States | 15 |
| NUTX | NUTEX HEALTH INC | NASDAQ | Health Information Services | A | $1.29B | $182.23 | -0.90% | $227.40M | 8.60x | 1.66 | United States | 50 |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | NYSE | Capital Markets | A | $1.26B | $47.32 | 0.57% | $119.00M | 42.63x | 0.93 | United States | 38 |
| CRTO | CRITEO SA | NASDAQ | Advertising Agencies | A | $1.08B | $20.59 | 1.48% | $219.28M | 6.60x | 0.79 | France | 51 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $1.01B | $13.95 | 0.72% | $98.00M | 14.38x | 0.23 | United States | 50 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $657.40M | $5.18 | -0.58% | $18.04M | -43.17x | 0.49 | United States | 20 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | NYSE | Specialty Retail | A | $529.15M | $14.18 | 3.81% | $145.14M | N/A | 6.80 | Mexico | 45 |
| VREX | VAREX IMAGING CORP | NASDAQ | Medical Devices | A | $497.90M | $11.94 | 0.51% | -$1.00M | -7.02x | 1.31 | United States | 24 |
| LE | LANDS' END INC | NASDAQ | Apparel Retail | A | $446.05M | $14.60 | -1.02% | $86.84M | 39.46x | 2.69 | United States | 32 |
| EGHT | 8X8 INC | NASDAQ | Software - Application | A | $275.89M | $1.99 | -1.00% | $51.06M | -49.75x | 4.04 | United States | 12 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $240.46M | $28.83 | 1.30% | $12.05M | 29.72x | 0.20 | United States | 54 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $230.96M | $12.39 | 1.14% | $11.65M | N/A | 0.39 | United States | 26 |
| LTRX | LANTRONIX INC | NASDAQ | Communication Equipment | A | $226.31M | $5.75 | 0.17% | -$5.00M | -22.12x | 0.61 | United States | 17 |
| CXDO | CREXENDO INC | NASDAQ | Telecom Services | A | $203.13M | $6.61 | 1.54% | $7.94M | 44.07x | 0.24 | United States | 44 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $181.20M | $8.91 | -0.56% | $24.16M | 34.27x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.